Margaret Pertzborn, M. Peinovich, L. W. Webster, Allison Cid, Sara E. Ausman, Christina G. Rivera
2026.2.19Journal of the American College of Clinical Pharmacy
tlooto Summary
The potential benefits of AMS in HaH and the role of infectious diseases (ID) pharmacists in optimizing antimicrobial therapy are explored and the potential challenges in implementing AMS are explored.
Abstract
Hospital‐at‐Home (HaH) programs provide acute care in patients' homes, reducing hospitalization and improving patient experience. While crucial in traditional settings, antimicrobial stewardship (AMS) in HaH programs remains understudied. This manuscript explores the potential benefits of AMS in HaH and the role of infectious diseases (ID) pharmacists in optimizing antimicrobial therapy. Key challenges in implementing AMS in HaH include medication delivery logistics, treatment regimen adjustments, and unique administration techniques. ID pharmacists can address these challenges by providing expertise in antimicrobial selection, dosing, and duration, as well as identifying opportunities for de‐escalation and intravenous (IV) to oral conversions. By integrating AMS into HaH programs, health care systems can improve patient outcomes, reduce antimicrobial resistance, and optimize resource utilization. Further research and training programs are needed to fully realize the potential of AMS in this emerging model of care.
Citation format
PERTZBORN, Margaret, et al. Optimizing antimicrobial stewardship in hospital‐at‐home programs: On behalf of the society of infectious diseases pharmacists. Journal of the American College of Clinical Pharmacy, 2026, 9(3): e70185.